The global Nucleic Acid And Gene Therapies In Neuromuscular Disorders market size is expected to be valued at US$ 7.88 Billion in 2023. With the increasing high incidence of cancer and other target diseases, the overall demand for Nucleic Acid and Gene Therapies in Neuromuscular Disorders is projected to grow at a CAGR of 9.5% between 2023 and 2033, totaling around US$ 19.52 Billion by 2033....